Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Erik Backhaus, Stefan Berg, Birger Trollfors, Rune Andersson, Elisabet Persson, Berndt E. B. Claesson, Peter Larsson, Elisabeth Ek, Lars Jonsson, Gunilla Rådberg, Siv Johansson, Torvald Ripa, Diana Karlsson & Kerstin Andersson. (2007) Antimicrobial susceptibility of invasive pneumococcal isolates from a region in south-west Sweden 1998–2001. Scandinavian Journal of Infectious Diseases 39:1, pages 19-27.
Read now
Read now
Articles from other publishers (24)
Erida Gjini & Sten Madec. (2021) The ratio of single to co‐colonization is key to complexity in interacting systems with multiple strains. Ecology and Evolution 11:13, pages 8456-8474.
Crossref
Crossref
Urban Johansson Kostenniemi, David Norman, Mats Sellin & Sven‐Arne Silfverdal. (2019)
Sustained reductions of invasive infectious disease following general infant
Haemophilus influenzae
type b and pneumococcal vaccination in a Swedish Arctic region
. Acta Paediatrica 108:10, pages 1871-1878.
Crossref
Crossref
Fernando Cobo, Maria Teresa Cabezas-Fernández & Maria Isabel Cabeza-Barrera. (2012) Streptococcus pneumoniae Bacteremia: Clinical and Microbiological Epidemiology in a Health Area of Southern Spain. Infectious Disease Reports 4:2, pages e29.
Crossref
Crossref
M. R. Moore & C. G. Whitney. (2008) Emergence of Nonvaccine Serotypes following Introduction of Pneumococcal Conjugate Vaccine: Cause and Effect?. Clinical Infectious Diseases 46:2, pages 183-185.
Crossref
Crossref
Lisa A. Jackson & Kathleen M. Neuzil. 2008. Vaccines. Vaccines
569
604
.
Katarzyna Grabowska, Liselotte Högberg, Pasi Penttinen, Åke Svensson & Karl Ekdahl. (2006) Occurrence of invasive pneumococcal disease and number of excess cases due to influenza. BMC Infectious Diseases 6:1.
Crossref
Crossref
Tom Jefferson, Eliana Ferroni, Filippo Curtale, Paolo Giorgi Rossi & Piero Borgia. (2006) Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old. The Lancet Infectious Diseases 6:7, pages 405-410.
Crossref
Crossref
E. Bouza, V. Pintado, S. Rivera, R. Blázquez, P. Muñoz, E. Cercenado, E. Loza, M. Rodríguez-Créixems & S. Moreno. (2005) Nosocomial bloodstream infections caused by Streptococcus pneumoniae. Clinical Microbiology and Infection 11:11, pages 919-924.
Crossref
Crossref
Benjamin M. Greenberg, Robert L. Atmar, Charles E. Stager & Stephen B. Greenberg. (2005) Bacteraemia in the elderly: predictors of outcome in an urban teaching hospital. Journal of Infection 50:4, pages 288-295.
Crossref
Crossref
Rafael E. CampoCarlos E. CampoGarnet PeterJessica ZuletaNatalie A. WahlayTimothy ClearyMichael A. KolberGordon M. Dickinson. (2005) Differences in Presentation and Outcome of Invasive Pneumococcal Disease among Patients with and without HIV Infection in the Pre-HAART Era. AIDS Patient Care and STDs 19:3, pages 141-149.
Crossref
Crossref
Román Pallarés. (2004) Mortalidad en la enfermedad neumocócica. Medicina Clínica 123:15, pages 578-579.
Crossref
Crossref
Andrej Trampuz, Andreas F. Widmer, Ursula Fluckiger, Monika Haenggi, Reno Frei & Werner Zimmerli. (2004) Changes in the Epidemiology of Pneumococcal Bacteremia in a Swiss University Hospital During a 15-Year Period, 1986-2000. Mayo Clinic Proceedings 79:5, pages 604-612.
Crossref
Crossref
J. Maugein, D. Guillemot, M.J. Dupont, T. Fosse, G. Laurans, M. Roussel-Delvallez, J. Thierry, M. Vergnaud, M. Weber & B. Poirier. (2003) Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties. Clinical Microbiology and Infection 9:4, pages 280-288.
Crossref
Crossref
Michael R. Jacobs. (2002)
In Vivo Veritas:
In Vitro Macrolide Resistance in Systemic
Streptococcus pneumoniae
Infections Does Result in Clinical Failure
. Clinical Infectious Diseases 35:5, pages 565-569.
Crossref
Crossref
R Dagan. (2002) IMMUNISATION WITH A PNEUMOCOCCAL 7‐VALENT CONJUGATE VACCINE. International Journal of Clinical Practice 56:4, pages 287-291.
Crossref
Crossref
Helena K. Parsons & David H. Dockrell. (2002) The burden of invasive pneumococcal disease and the potential for reduction by immunisation. International Journal of Antimicrobial Agents 19:2, pages 85-93.
Crossref
Crossref
Åke Örtqvist. 2001. Community-Acquired Pneumonia. Community-Acquired Pneumonia
427
454
.
William P Hausdorff, George Siber & Peter R Paradiso. (2001) Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. The Lancet 357:9260, pages 950-952.
Crossref
Crossref
W Baine. (2001) The Epidemiology of Hospitalization of Elderly Americans for Septicemia or Bacteremia in 1991–1998 Application of Medicare Claims Data. Annals of Epidemiology 11:2, pages 118-126.
Crossref
Crossref
EVA MELANDER, KARL EKDAHL MD, G??RAN J??NSSON & SIGVARD M??LSTAD. (2000) Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. The Pediatric Infectious Disease Journal 19:12, pages 1172-1177.
Crossref
Crossref
M Eriksson, B Henriques & K Ekdahl. (2007) Epidemiology of pneumococcal infections in Swedish children. Acta Paediatrica 89:s435, pages 35-39.
Crossref
Crossref
MS Kaltoft, N Zeuthen & HB Konradsen. (2007) Epidemiology of invasive pneumococcal infections in children aged 0–6 years in Denmark: a 19‐year nationwide surveillance study. Acta Paediatrica 89:s435, pages 3-10.
Crossref
Crossref
W. P. Hausdorff, J. Bryant, P. R. Paradiso & G. R. Siber. (2000) Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I. Clinical Infectious Diseases 30:1, pages 100-121.
Crossref
Crossref
CARL KAMME, KARL EKDAHL & SIGVARD MÖLSTAD. (1999) Penicillin-Resistant Pneumococci in Southern Sweden, 1993–1997. Microbial Drug Resistance 5:1, pages 31-36.
Crossref
Crossref